Computerized Thermal Imaging CIO (formerly COII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Computerized Thermal Imaging CIO (formerly COII)

CIO 6.800

-0.4%

Dec 4 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tom Knudsen who wrote (6)	3/13/1998 8:29:00 PM
From: Gerald Hayward	Read Replies (1) of 6039

As a physician, maybe I can respond to part of the question. It is true that there is some pressure to remove palpable masses in the breast both as good medical care and because most patients are concerned about the insecurity of not knowing and would rather have a definitive diagnosis. The value of mammography and hopefully CTI is to detect cancer that is not palpable. The assurance of 85% accuracy allows a huge step forward. Keep in mind that physicians are also under tremendous pressure to cut costs, and if they can be confident in a test, they can find it much easier to watch and repeat the exam particularly if the exam is reasonably priced, and not invasive or painful. Believe me they are much more anxious to avoid surgery if they can, and so are the managed care programs to which they belong.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next